BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 10891771)

  • 1. [Screening for hepatocellular carcinoma in cirrhotic patients].
    Beaugrand M
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
    Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
    Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: status in the era of liver transplantation.
    Singhal A; Jabbour N
    J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mass screening for high risk group of hepatocellular carcinoma].
    Kawanishi T; Mima S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():786-90. PubMed ID: 11762057
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome.
    Stravitz RT; Heuman DM; Chand N; Sterling RK; Shiffman ML; Luketic VA; Sanyal AJ; Habib A; Mihas AA; Giles HC; Maluf DG; Cotterell AH; Posner MP; Fisher RA
    Am J Med; 2008 Feb; 121(2):119-26. PubMed ID: 18261500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
    Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
    Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High risk group and screening methods of hepatocellular carcinoma].
    Matsushita E; Kaneko S; Kobayashi K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():229-35. PubMed ID: 11761945
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is the value of systematic screening of hepatocellular carcinomas in patients with liver cirrhosis?].
    Pateron D
    Gastroenterol Clin Biol; 1992; 16(11):908-9. PubMed ID: 1336468
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
    Henrion J; Libon E; De Maeght S; Deltenre P; Schapira M; Ghilain JM; Maisin JM; Heller FR
    Gastroenterol Clin Biol; 2003 May; 27(5):534-9. PubMed ID: 12843918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: risk factors and natural history.
    Martin P
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S87-91. PubMed ID: 9742499
    [No Abstract]   [Full Text] [Related]  

  • 11. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kuzuya T; Nonogaki K; Shimizu J
    J Gastroenterol Hepatol; 2005 Jun; 20(6):963-5. PubMed ID: 15946154
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma.
    Manns MP; Kubicka S
    Digestion; 1997; 58 Suppl 1():69-75. PubMed ID: 9225098
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular carcinoma.
    Marrero JA
    Curr Opin Gastroenterol; 2006 May; 22(3):248-53. PubMed ID: 16550039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
    Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
    Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
    Donato MF; Arosio E; Del Ninno E; Ronchi G; Lampertico P; Morabito A; Balestrieri MR; Colombo M
    Hepatology; 2001 Sep; 34(3):523-8. PubMed ID: 11526538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
    Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma: risk factors and screening].
    Beaugrand M; N'kontchou G
    Bull Acad Natl Med; 2012 Jan; 196(1):85-94; discussion 94-6. PubMed ID: 23259336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma development in cirrhosis.
    Okuda H
    Best Pract Res Clin Gastroenterol; 2007; 21(1):161-73. PubMed ID: 17223503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocarcinoma, liver cirrhosis and the HBV].
    Núñez-Cortés JM
    Rev Clin Esp; 1993 Apr; 192(7):305-7. PubMed ID: 8388573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.